153
Views
25
CrossRef citations to date
0
Altmetric
Original

Myeloperoxidase-mediated LDL oxidation and endothelial cell toxicity of oxidized LDL: attenuation by (−)-epicatechin

, &
Pages 1076-1085 | Received 13 May 2006, Published online: 07 Jul 2009
 

Abstract

Recent data suggest an inverse epidemiological association between intake of flavanol-rich cocoa products and cardiac mortality. Potential beneficial effect of cocoa may be attributed to flavanol-mediated improvement of endothelial function, as well as to enhancement of bioavailability and bioactivity of nitric oxide in vivo. ( − )-Epicatechin is one bioactive flavanol found in cocoa. This review deals with protective actions of ( − )-epicatechin on two key processes in atherogenesis, oxidation of LDL and damage to endothelial cell by oxidized LDL (oxLDL), with emphasis on data from this laboratory. ( − )-Epicatechin not only abrogates or attenuates LDL oxidation but also counteracts deleterious actions of oxLDL on vascular endothelial cells. These protective actions are only partially shared by other vasoprotective agents such as vitamins C and E or aspirin. Thus, ( − )-epicatechin appears to be a pleiotropic protectant for both LDL and endothelial cells.

Abbreviations
ASA=

acetylsalicylic acid

BrdU=

5-bromo-2′-deoxyuridine

HUVEC=

human umbilical vein endothelial cells

LDH=

lactate dehydrogenase

LDL=

low-density lipoprotein

oxLDL=

oxidatively modified low-density lipoprotein

MPO=

myeloperoxidase

MTT=

3-[4,5-dimethylthiazol-2-yl]2,5-diphenyltetrazolium bromide

REM=

relative electrophoretic mobility

ROS=

reactive oxygen species

Abbreviations
ASA=

acetylsalicylic acid

BrdU=

5-bromo-2′-deoxyuridine

HUVEC=

human umbilical vein endothelial cells

LDH=

lactate dehydrogenase

LDL=

low-density lipoprotein

oxLDL=

oxidatively modified low-density lipoprotein

MPO=

myeloperoxidase

MTT=

3-[4,5-dimethylthiazol-2-yl]2,5-diphenyltetrazolium bromide

REM=

relative electrophoretic mobility

ROS=

reactive oxygen species

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.